Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Cadman

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1985
Clinical pharmacology of high-dose cisplatin by Corden et alM W DeGregorio, J R Wilbur, T J Crowley, et al.
American Journal of Clinical Oncology|August 1, 1982
Splenectomy in Hodgkin's disease: no therapeutic benefitL N Newcomer, E C Cadman, L R Prosnitz, et al.
The Journal of Biocommunication|January 30, 1999
A web-based risk management and medical-legal curriculum for graduate medical educationT J Balcezak, P Lynch, S Jackson, et al.
Cancer Treatment Reports|January 1, 1985
Altered plasma kinetics of 5-FU at high dosage in rat and manP M Schwartz, P J Turek, C M Hyde, et al.
Journal of the American Academy of Dermatology|January 1, 1987
Combined total body electron beam irradiation and chemotherapy for mycosis fungoidesI M Braverman, N B Yager, M Chen, et al.
The New England Journal of Medicine|December 11, 1980
Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groupsA F Stewart, R Horst, L J Deftos, et al.
The American Journal of Managed Care|September 8, 2000
Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical centerT J Balcezak, H M Krumholz, G S Getnick, et al.
Cancer|October 1, 1980
Curative potential of combined modality therapy for advanced Hodgkin's diseaseL R Farber, L R Prosnitz, E C Cadman, et al.
Cancer|October 1, 1979
High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaS A Rudnick, E C Cadman, R L Capizzi, et al.
Cancer|January 15, 1982
Bone involvement in Hodgkin's diseaseL N Newcomer, M B Silverstein, E C Cadman, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|January 1, 1985
Clinical pharmacology of high-dose cisplatin by Corden et alM W DeGregorio, J R Wilbur, T J Crowley, et al.
American Journal of Clinical Oncology|August 1, 1982
Splenectomy in Hodgkin's disease: no therapeutic benefitL N Newcomer, E C Cadman, L R Prosnitz, et al.
The Journal of Biocommunication|January 30, 1999
A web-based risk management and medical-legal curriculum for graduate medical educationT J Balcezak, P Lynch, S Jackson, et al.
Cancer Treatment Reports|January 1, 1985
Altered plasma kinetics of 5-FU at high dosage in rat and manP M Schwartz, P J Turek, C M Hyde, et al.
Journal of the American Academy of Dermatology|January 1, 1987
Combined total body electron beam irradiation and chemotherapy for mycosis fungoidesI M Braverman, N B Yager, M Chen, et al.
The New England Journal of Medicine|December 11, 1980
Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groupsA F Stewart, R Horst, L J Deftos, et al.
The American Journal of Managed Care|September 8, 2000
Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical centerT J Balcezak, H M Krumholz, G S Getnick, et al.
Cancer|October 1, 1980
Curative potential of combined modality therapy for advanced Hodgkin's diseaseL R Farber, L R Prosnitz, E C Cadman, et al.
Cancer|October 1, 1979
High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaS A Rudnick, E C Cadman, R L Capizzi, et al.
Cancer|January 15, 1982
Bone involvement in Hodgkin's diseaseL N Newcomer, M B Silverstein, E C Cadman, et al.
Pageof 5